Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5 USD | -1.38% | +9.54% | +22.57% |
05-13 | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
05-09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.57% | 174M | |
+31.52% | 50.85B | |
+1.06% | 42.82B | |
+48.77% | 42.03B | |
-4.22% | 29.55B | |
+10.77% | 26.11B | |
-22.26% | 19.13B | |
+7.56% | 13.05B | |
+26.90% | 12.16B | |
+23.18% | 12.08B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Achieve Life Sciences : Alliance Global Partners Starts Achieve Life Sciences at Buy with $25 Price Target